Hyperferritinemia in critically ill COVID-19 patients – Is ferritin the product of inflammation or a pathogenic mediator?

Jenifer Gómez-Pastora; Mitchell Weigand; James Kim; Xian Wu; Jacob Strayer; Andre F. Palmer; Maciej Zborowski; Mark Yazer; Jeffrey J. Chalmers

doi:10.1016/j.cca.2020.06.033

Hyperferritinemia in critically ill COVID-19 patients – Is ferritin the product of inflammation or a pathogenic mediator?

Jenifer Gómez-Pastora
, Mitchell Weigand
, James Kim
, Xian Wu
, Jacob Strayer
, Andre F. Palmer
, Maciej Zborowski
, Mark Yazer
, Jeffrey J. Chalmers

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	249-251
Number of pages	3
Journal	Clinica Chimica Acta
Volume	509
DOIs	https://doi.org/10.1016/j.cca.2020.06.033
State	Published - Oct 2020

Access to Document

10.1016/j.cca.2020.06.033

Cite this

@article{df455ace338b4ab18ece7e8f4389f3b6,

title = "Hyperferritinemia in critically ill COVID-19 patients {\textendash} Is ferritin the product of inflammation or a pathogenic mediator?",

author = "Jenifer G{\'o}mez-Pastora and Mitchell Weigand and James Kim and Xian Wu and Jacob Strayer and Palmer, \{Andre F.\} and Maciej Zborowski and Mark Yazer and Chalmers, \{Jeffrey J.\}",

note = "Funding Information: Financial support from the National Heart, Lung, and Blood Institute from the United States National Institutes of Health ( 1R01HL131720-01A1 ) is acknowledged. The authors are also grateful to all the healthcare operators as well as all the essential workers on the frontlines during the COVID-19 pandemic.",

year = "2020",

month = oct,

doi = "10.1016/j.cca.2020.06.033",

language = "English",

volume = "509",

pages = "249--251",